Dow Up0.51% Nasdaq Up0.24%

Synageva BioPharma Corp. (GEVA)

-NMS
74.74 Up 3.67(5.16%) Nov 21, 4:00PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (95,450) (42,949) (25,306)
Operating Activities, Cash Flows Provided By or Used In
Depreciation8,052  4,582  1,034  
Adjustments To Net Income11,687  5,315  892  
Changes In Accounts Receivables1,226  (388)1,586  
Changes In Liabilities1,986  3,829  5,669  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(2,503)(1,324)(464)
Total Cash Flow From Operating Activities (75,002) (30,935) (16,589)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(14,621)(3,746)(683)
Investments(154,049)(195,365) -  
Other Cash flows from Investing Activities(4,435)(394)50,107  
Total Cash Flows From Investing Activities (173,105) (199,505) 49,424  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock286,352  194,097  186  
Net Borrowings -   -  12,500  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 286,352   194,097   12,686  
Effect Of Exchange Rate Changes9  (6)(4)
Change In Cash and Cash Equivalents 38,254   (36,349) 45,517  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.